Stimuli-sensitive nanopreparations for combination cancer therapy

Journal of Controlled Release

Volumn 190, Issue , 2014, Pages 352-370

  Jhaveri, Aditi ^a   Deshpande, Pranali ^a   Torchilin, Vladimir ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Co delivery; Combination; Multifunctional; Nanoparticles; Stimuli sensitive

Indexed keywords

ANTIBODIES; DRUG DELIVERY; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; REDOX REACTIONS;

BIOLOGICAL THERAPEUTICS; CHEMOTHERAPEUTIC AGENTS; CO DELIVERIES; COMBINATION; COMBINATION APPROACHES; DRUG DELIVERY STRATEGIES; MULTIFUNCTIONAL; STIMULI-SENSITIVE; TUMOR MICROENVIRONMENT;

DISEASES;

ANTIBODY; ANTIINFECTIVE AGENT; AZOBENZENE; BEVACIZUMAB; BORTEZOMIB; CARBOPLATIN; CISPLATIN; DISULFIRAM; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; HISTONE DEACETYLASE INHIBITOR; IMATINIB; LIGAND; MAGNETIC NANOPARTICLE; MEGESTROL ACETATE; METAL; METHOTREXATE; NANOCARRIER; OLIGONUCLEOTIDE; OXALIPLATIN; PACLITAXEL; PROTEIN; RAPAMYCIN; SILICON DIOXIDE; SMALL INTERFERING RNA; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TRASTUZUMAB; 10 HYDROXYCAMPTOTHECIN; DAUNORUBICIN; DENDRIMER; DNA; ENZYME; HYDRAZONE DERIVATIVE; LIPOSOME; MALEIMIDE; MESOPOROUS SILICA NANOPARTICLE; MULTIDRUG RESISTANCE PROTEIN 1; NANOMATERIAL; NANOPARTICLE; SHORT HAIRPIN RNA; STIMULI SENSITIVE NANOPREPARATION; SURVIVIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DELAYED RELEASE FORMULATION; DRUG CARRIER;

ASSOCIATION; CANCER THERAPY; CARCINOGENESIS; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TARGETING; GENE TARGETING; HUMAN; HYPERTHERMIA; LIGHT; MAGNETIC FIELD; MOLECULARLY TARGETED THERAPY; NANOTECHNOLOGY; NEOPLASM; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PH; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STIMULUS RESPONSE; THERMAL ANALYSIS; TUMOR MICROENVIRONMENT; ULTRASOUND; DRUG RESISTANCE; HYDROGEL; MAGNETISM; MICELLE; TEMPERATURE; TREATMENT RESPONSE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG COMBINATION; NEOPLASMS;

ANTINEOPLASTIC AGENTS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG THERAPY, COMBINATION; HUMANS; HYDROGEN-ION CONCENTRATION; NANOPARTICLES; NEOPLASMS;

EID: 84906785933     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.05.002     Document Type: Review

References (178)

1. S. Mura, J. Nicolas, and P. Couvreur Stimuli-responsive nanocarriers for drug delivery Nat. Mater. 12 2013 991 1003
2. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2 2007 751 760 (Pubitemid 350223348)
3. V.P. Torchilin Multifunctional nanocarriers Adv. Drug Deliv. Rev. 58 2006 1532 1555 (Pubitemid 44822608)
4. A.Z. Wang, R. Langer, and O.C. Farokhzad Nanoparticle delivery of cancer drugs Annu. Rev. Med. 63 2012 185 198
5. V. Torchilin Multifunctional and stimuli-sensitive pharmaceutical nanocarriers Eur. J. Pharm. Biopharm. 71 2009 431 444
6. N. Kamaly, Z. Xiao, P.M. Valencia, A.F. Radovic-Moreno, and O.C. Farokhzad Targeted polymeric therapeutic nanoparticles: design, development and clinical translation Chem. Soc. Rev. 41 2012 2971 3010
7. Y.L. Colson, and M.W. Grinstaff Biologically responsive polymeric nanoparticles for drug delivery Adv. Mater. 24 2012 3878 3886
8. L.E. Gerweck, and K. Seetharaman Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer Cancer Res. 56 1996 1194 1198 (Pubitemid 26080953)
9. I.F. Tannock, and D. Rotin Acid pH in tumors and its potential for therapeutic exploitation Cancer Res. 49 1989 4373 4384 (Pubitemid 19208329)
10. A. Russo, W. DeGraff, N. Friedman, and J.B. Mitchell Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs Cancer Res. 46 1986 2845 2848 (Pubitemid 16074292)
11. G. Saito, J.A. Swanson, and K.D. Lee Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities Adv. Drug Deliv. Rev. 55 2003 199 215 (Pubitemid 36135916)
12. R. de la Rica, D. Aili, and M.M. Stevens Enzyme-responsive nanoparticles for drug release and diagnostics Adv. Drug Deliv. Rev. 64 2012 967 978
13. J.E. Ghadiali, and M.M. Stevens Enzyme-responsive nanoparticle systems Adv. Mater. 20 2008 4359 4363
14. F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A. Mantovani Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis 30 2009 1073 1081
15. S.H. Gromkowski, J. Yagi, and C.A. Janeway Jr. Elevated temperature regulates tumor necrosis factor-mediated immune killing Eur. J. Immunol. 19 1989 1709 1714 (Pubitemid 19243892)
16. C. Stefanadis, C. Chrysochoou, D. Markou, K. Petraki, D.B. Panagiotakos, C. Fasoulakis, A. Kyriakidis, C. Papadimitriou, and P.K. Toutouzas Increased temperature of malignant urinary bladder tumors in vivo: the application of a new method based on a catheter technique J. Clin. Oncol. 19 2001 676 681 (Pubitemid 32119080)
17. L. Ma, M. Kohli, and A. Smith Nanoparticles for combination drug therapy ACS Nano 7 2013 9518 9525
18. R.R. Sawant, A.M. Jhaveri, and V.P. Torchilin Immunomicelles for advancing personalized therapy Adv. Drug Deliv. Rev. 64 2012 1436 1446
19. B. Al-Lazikani, U. Banerji, and P. Workman Combinatorial drug therapy for cancer in the post-genomic era Nat. Biotechnol. 30 2012 679 692
20. T. Lammers, F. Kiessling, W.E. Hennink, and G. Storm Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress J. Control. Release 161 2012 175 187
21. N.M. Sakhrani, and H. Padh Organelle targeting: third level of drug targeting Drug Des. Devel. Ther. 7 2013 585 599
22. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 1986 6387 6392 (Pubitemid 17221789)
23. K. Maruyama Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects Adv. Drug Deliv. Rev. 63 2011 161 169
24. R.R. Sawant, and V.P. Torchilin Challenges in development of targeted liposomal therapeutics AAPS J. 14 2012 303 315
25. J.L. Arias Drug targeting strategies in cancer treatment: an overview Mini Rev. Med. Chem. 11 2011 1 17
26. S. Sultana, M.R. Khan, M. Kumar, S. Kumar, and M. Ali Nanoparticles-mediated drug delivery approaches for cancer targeting: a review J. Drug Target. 21 2013 107 125
27. F. Danhier, O. Feron, and V. Preat To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Control. Release 148 2010 135 146
28. M. Talekar, J. Kendall, W. Denny, and S. Garg Targeting of nanoparticles in cancer: drug delivery and diagnostics Anticancer. Drugs 22 2011 949 962
29. Y. Li, G.H. Gao, and D.S. Lee Stimulus-sensitive polymeric nanoparticles and their applications as drug and gene carriers Adv. Healthc. Mater. 2 2013 388 417
30. H. Wu, L. Zhu, and V.P. Torchilin pH-sensitive poly(histidine)-PEG/DSPE- PEG co-polymer micelles for cytosolic drug delivery Biomaterials 34 2013 1213 1222
31. G. Li, Y. Meng, L. Guo, T. Zhang, and J. Liu Formation of thermo-sensitive polyelectrolyte complex micelles from two biocompatible graft copolymers for drug delivery J. Biomed. Mater. Res. A 2013
32. L. Zhu, P. Kate, and V.P. Torchilin Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting ACS Nano 6 2012 3491 3498
33. Y. Zhao, E.B. Butler, and M. Tan Targeting cellular metabolism to improve cancer therapeutics Cell Death Dis. 4 2013 e532
34. E. Fleige, M.A. Quadir, and R. Haag Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications Adv. Drug Deliv. Rev. 64 2012 866 884
35. F. Perche, and V.P. Torchilin Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting J. Drug Deliv. 2013 2013 705265
36. M.R. Preiss, and G.D. Bothun Stimuli-responsive liposome-nanoparticle assemblies Expert Opin. Drug Deliv. 8 2011 1025 1040
37. J. Zhuang, M.R. Gordon, J. Ventura, L. Li, and S. Thayumanavan Multi-stimuli responsive macromolecules and their assemblies Chem. Soc. Rev. 42 2013 7421 7435
38. R. Cheng, F. Meng, C. Deng, H.A. Klok, and Z. Zhong Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery Biomaterials 34 2013 3647 3657
39. J.P. Gillet, and M.M. Gottesman Mechanisms of multidrug resistance in cancer Methods Mol. Biol. 596 2010 47 76
40. L.D. Cripe, H. Uno, E.M. Paietta, M.R. Litzow, R.P. Ketterling, J.M. Bennett, J.M. Rowe, H.M. Lazarus, S. Luger, and M.S. Tallman Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999 Blood 116 2010 4077 4085
41. P. Ruff, D.A. Vorobiof, J.P. Jordaan, G.S. Demetriou, S.D. Moodley, A.L. Nosworthy, I.D. Werner, J. Raats, and L.J. Burgess A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen Cancer Chemother. Pharmacol. 64 2009 763 768
42. T.A. Yap, A. Omlin, and J.S. de Bono Development of therapeutic combinations targeting major cancer signaling pathways J. Clin. Oncol. 31 2013 1592 1605
43. A.L. Jackman, S. Kaye, and P. Workman The combination of cytotoxic and molecularly targeted therapies - can it be done? Drug Discov. Today Ther. Strateg. 1 2004 445 454 (Pubitemid 40197590)
44. S. Kummar, H.X. Chen, J. Wright, S. Holbeck, M.D. Millin, J. Tomaszewski, J. Zweibel, J. Collins, and J.H. Doroshow Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements Nat. Rev. Drug Discov. 9 2010 843 856
45. C.K. Chen, W.C. Law, R. Aalinkeel, Y. Yu, B. Nair, J. Wu, S. Mahajan, J.L. Reynolds, Y. Li, C.K. Lai, E.S. Tzanakakis, S.A. Schwartz, P.N. Prasad, and C. Cheng Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug-gene co-delivery to cancer cells Nanoscale 6 2014 1567 1572
46. W. Chen, Y. Yuan, D. Cheng, J. Chen, L. Wang, and X. Shuai Co-Delivery of Doxorubicin and siRNA with Reduction and pH Dually Sensitive Nanocarrier for Synergistic Cancer Therapy 2014 Small
47. Z.J. Deng, S.W. Morton, E. Ben-Akiva, E.C. Dreaden, K.E. Shopsowitz, and P.T. Hammond Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment ACS Nano 7 2013 9571 9584
48. Y. Zhang, N.M. Schwerbrock, A.B. Rogers, W.Y. Kim, and L. Huang Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC Mol. Ther. 21 2013 1559 1569
49. L. Zhu, F. Perche, T. Wang, and V.P. Torchilin Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs Biomaterials 35 2014 4213 4222
50. T.C. Chou Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies Pharmacol. Rev. 58 2006 621 681
51. F. Greco, and M.J. Vicent Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines Adv. Drug Deliv. Rev. 61 2009 1203 1213
52. C.M. Hu, S. Aryal, and L. Zhang Nanoparticle-assisted combination therapies for effective cancer treatment Ther. Deliv. 1 2010 323 334
53. A. Eldar-Boock, D. Polyak, A. Scomparin, and R. Satchi-Fainaro Nano-sized polymers and liposomes designed to deliver combination therapy for cancer Curr. Opin. Biotechnol. 24 2013 682 689
54. S. Ganta, H. Devalapally, A. Shahiwala, and M. Amiji A review of stimuli-responsive nanocarriers for drug and gene delivery J. Control. Release 126 2008 187 204
55. T.R. Kyriakides, C.Y. Cheung, N. Murthy, P. Bornstein, P.S. Stayton, and A.S. Hoffman pH-sensitive polymers that enhance intracellular drug delivery in vivo J. Control. Release 78 2002 295 303 (Pubitemid 34081874)
56. A.J. Convertine, C. Diab, M. Prieve, A. Paschal, A.S. Hoffman, P.H. Johnson, and P.S. Stayton pH-responsive polymeric micelle carriers for siRNA drugs Biomacromolecules 11 2010 2904 2911
57. B. Albarran, A.S. Hoffman, and P.S. Stayton Efficient intracellular delivery of a pro-apoptotic peptide with a pH-responsive carrier React. Funct. Polym. 71 2011 261 265
58. C.Y. Wang, and L. Huang Highly efficient DNA delivery mediated by pH-sensitive immunoliposomes Biochemistry (Mosc) 28 1989 9508 9514 (Pubitemid 20000730)
59. J. Connor, and L. Huang pH-sensitive immunoliposomes as an efficient and target-specific carrier for antitumor drugs Cancer Res. 46 1986 3431 3435 (Pubitemid 16096885)
60. E. Ducat, J. Deprez, A. Gillet, A. Noel, B. Evrard, O. Peulen, and G. Piel Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: benefits over classical vesicles Int. J. Pharm. 420 2011 319 332
61. A.A. Kale, and V.P. Torchilin Environment-responsive multifunctional liposomes Methods Mol. Biol. 605 2010 213 242
62. Z. Huang, X. Guo, W. Li, J.A. MacKay, and F.C. Szoka Jr. Acid-triggered transformation of diortho ester phosphocholine liposome J. Am. Chem. Soc. 128 2006 60 61 (Pubitemid 43100848)
63. J.A. Boomer, and D.H. Thompson Synthesis of acid-labile diplasmenyl lipids for drug and gene delivery applications Chem. Phys. Lipids 99 1999 145 153 (Pubitemid 29229777)
64. Y. Gu, Y. Zhong, F. Meng, R. Cheng, C. Deng, and Z. Zhong Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy Biomacromolecules 14 2013 2772 2780
65. J. Zou, F. Zhang, S. Zhang, S.F. Pollack, M. Elsabahy, J. Fan, and K.L. Wooley Poly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery Adv. Healthc. Mater. 3 2014 441 448
66. L. Zhu, Z. Ye, K. Cheng, D.D. Miller, and R.I. Mahato Site-specific delivery of oligonucleotides to hepatocytes after systemic administration Bioconjug. Chem. 19 2008 290 298 (Pubitemid 351213861)
67. S. Biswas, N.S. Dodwadkar, R.R. Sawant, and V.P. Torchilin Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization Bioconjug. Chem. 22 2011 2005 2013
68. X. Su, J. Fricke, D.G. Kavanagh, and D.J. Irvine In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles Mol. Pharm. 8 2011 774 787
69. E.S. Lee, D. Kim, Y.S. Youn, K.T. Oh, and Y.H. Bae A virus-mimetic nanogel vehicle Angew. Chem. Int. Ed. Engl. 47 2008 2418 2421
70. X.-B. Xiong, and A. Lavasanifar Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin ACS Nano 5 2011 5202 5213
71. Y. Zhang, C. Xiao, M. Li, J. Chen, J. Ding, C. He, X. Zhuang, and X. Chen Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy Macromol. Biosci. 13 2013 584 594
72. X. Ma, Y. Zhao, K.W. Ng, and Y. Zhao Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery Chemistry 19 2013 15593 15603
73. H. Yu, Z. Xu, X. Chen, L. Xu, Q. Yin, Z. Zhang, and Y. Li Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel Macromol. Biosci. 14 2014 100 109
74. X. Duan, J. Xiao, Q. Yin, Z. Zhang, H. Yu, S. Mao, and Y. Li Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram ACS Nano 7 2013 5858 5869
75. Y. Mi, J. Zhao, and S.-S. Feng Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer J. Control. Release 169 2013 185 192
76. C. Liu, F. Liu, L. Feng, M. Li, J. Zhang, and N. Zhang The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles Biomaterials 34 2013 2547 2564
77. R. Roy, J. Yang, and M.A. Moses Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer J. Clin. Oncol. 27 2009 5287 5297
78. K. Kessenbrock, V. Plaks, and Z. Werb Matrix metalloproteinases: regulators of the tumor microenvironment Cell 141 2010 52 67
79. C. Gialeli, A.D. Theocharis, and N.K. Karamanos Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting FEBS J. 278 2011 16 27
80. J.B. Park, C.S. Lee, J.H. Jang, J. Ghim, Y.J. Kim, S. You, D. Hwang, P.G. Suh, and S.H. Ryu Phospholipase signalling networks in cancer Nat. Rev. Cancer 12 2012 782 792
81. P. Meers Enzyme-activated targeting of liposomes Adv. Drug Deliv. Rev. 53 2001 265 272 (Pubitemid 34026337)
82. J. Banerjee, A.J. Hanson, B. Gadam, A.I. Elegbede, S. Tobwala, B. Ganguly, A.V. Wagh, W.W. Muhonen, B. Law, J.B. Shabb, D.K. Srivastava, and S. Mallik Release of liposomal contents by cell-secreted matrix metalloproteinase-9 Bioconjug. Chem. 20 2009 1332 1339
83. S.M. Ellerbroek, L.G. Hudson, and M.S. Stack Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion Int. J. Cancer 78 1998 331 337 (Pubitemid 28445371)
84. F. Loechel, J.W. Fox, G. Murphy, R. Albrechtsen, and U.M. Wewer ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3 Biochem. Biophys. Res. Commun. 278 2000 511 515
85. G. Murphy The ADAMs: signalling scissors in the tumour microenvironment Nat. Rev. Cancer 8 2008 929 941
86. N. Rocks, G. Paulissen, M. El Hour, F. Quesada, C. Crahay, M. Gueders, J.M. Foidart, A. Noel, and D. Cataldo Emerging roles of ADAM and ADAMTS metalloproteinases in cancer Biochimie 90 2008 369 379 (Pubitemid 351172571)
87. M. El Hour, A. Moncada-Pazos, S. Blacher, A. Masset, S. Cal, S. Berndt, J. Detilleux, L. Host, A.J. Obaya, C. Maillard, J.M. Foidart, F. Ectors, A. Noel, and C. Lopez-Otin Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis Oncogene 29 2010 3025 3032
88. Z. Zha, S. Zhang, Z. Deng, Y. Li, C. Li, and Z. Dai Enzyme-responsive copper sulphide nanoparticles for combined photoacoustic imaging, tumor-selective chemotherapy and photothermal therapy Chem. Commun. (Camb.) 49 2013 3455 3457
89. Z. Chen, Z. Li, Y. Lin, M. Yin, J. Ren, and X. Qu Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery Chemistry 19 2013 1778 1783
90. K.K. Vangara, J.L. Liu, and S. Palakurthi Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer Anticancer Res. 33 2013 2425 2434
91. C.S. Lee, W. Park, S.J. Park, and K. Na Endolysosomal environment-responsive photodynamic nanocarrier to enhance cytosolic drug delivery via photosensitizer-mediated membrane disruption Biomaterials 34 2013 9227 9236
92. C. Foged, H.M. Nielsen, and S. Frokjaer Phospholipase A2 sensitive liposomes for delivery of small interfering RNA (siRNA) J. Liposome Res. 17 2007 191 196 (Pubitemid 350133586)
93. T. Kaasgaard, T.L. Andresen, S.S. Jensen, R.O. Holte, L.T. Jensen, and K. Jorgensen Liposomes containing alkylated methotrexate analogues for phospholipase A(2) mediated tumor targeted drug delivery Chem. Phys. Lipids 157 2009 94 103
94. T.J. Harris, G. von Maltzahn, M.E. Lord, J.H. Park, A. Agrawal, D.H. Min, M.J. Sailor, and S.N. Bhatia Protease-triggered unveiling of bioactive nanoparticles Small 4 2008 1307 1312
95. L. Zhu, and V.P. Torchilin Stimulus-responsive nanopreparations for tumor targeting Integr. Biol. 5 2013 96 107
96. D. Roy, J.N. Cambre, and B.S. Sumerlin Future perspectives and recent advances in stimuli-responsive materials Prog. Polym. Sci. 35 2010 278 301
97. C. Jedeszko, and B.F. Sloane Cysteine cathepsins in human cancer Biol. Chem. 385 2004 1017 1027 (Pubitemid 39600309)
98. R. Duncan Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt Adv. Drug Deliv. Rev. 61 2009 1131 1148
99. I. Podgorski, and B.F. Sloane Cathepsin B and its role(s) in cancer progression Biochem. Soc. Symp. 2003 263 276 (Pubitemid 38497232)
100. L. Zhu, T. Wang, F. Perche, A. Taigind, and V.P. Torchilin Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety Proc. Natl. Acad. Sci. U. S. A. 110 2013 17047 17052
101. W. Gao, B. Xiang, T.T. Meng, F. Liu, and X.R. Qi Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides Biomaterials 34 2013 4137 4149
102. N.Q. Shi, W. Gao, B. Xiang, and X.R. Qi Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage Int. J. Nanomedicine 7 2012 1613 1621
103. V.K. Garripelli, J.K. Kim, S. Son, W.J. Kim, M.A. Repka, and S. Jo Matrix metalloproteinase-sensitive thermogelling polymer for bioresponsive local drug delivery Acta Biomater. 7 2011 1984 1992
104. T. Tokatlian, C.T. Shrum, W.M. Kadoya, and T. Segura Protease degradable tethers for controlled and cell-mediated release of nanoparticles in 2- and 3-dimensions Biomaterials 31 2010 8072 8080
105. H. Hatakeyama, E. Ito, H. Akita, M. Oishi, Y. Nagasaki, S. Futaki, and H. Harashima A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo J. Control. Release 139 2009 127 132
106. T.L. Andresen, D.H. Thompson, and T. Kaasgaard Enzyme-triggered nanomedicine: drug release strategies in cancer therapy Mol. Membr. Biol. 27 2010 353 363
107. S. Huang, K. Shao, Y. Liu, Y. Kuang, J. Li, S. An, Y. Guo, H. Ma, and C. Jiang Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis ACS Nano 7 2013 2860 2871
108. S.Y. Qin, J. Feng, L. Rong, H.Z. Jia, S. Chen, X.J. Liu, G.F. Luo, R.X. Zhuo, and X.Z. Zhang Theranostic GO-based nanohybrid for tumor induced imaging and potential combinational tumor therapy Small 10 2014 599 608
109. M. Calderón, R. Graeser, F. Kratz, and R. Haag Development of enzymatically cleavable prodrugs derived from dendritic polyglycerol Bioorg. Med. Chem. Lett. 19 2009 3725 3728
110. F.Q. Schafer, and G.R. Buettner Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple Free Radic. Biol. Med. 30 2001 1191 1212 (Pubitemid 32463931)
111. J. Li, M. Huo, J. Wang, J. Zhou, J.M. Mohammad, Y. Zhang, Q. Zhu, A.Y. Waddad, and Q. Zhang Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel Biomaterials 33 2012 2310 2320
112. J.M. Estrela, A. Ortega, and E. Obrador Glutathione in cancer biology and therapy Crit. Rev. Clin. Lab. Sci. 43 2006 143 181 (Pubitemid 43860449)
113. G.K. Balendiran, R. Dabur, and D. Fraser The role of glutathione in cancer Cell Biochem. Funct. 22 2004 343 352 (Pubitemid 39518098)
114. N. Ballatori, S.M. Krance, S. Notenboom, S. Shi, K. Tieu, and C.L. Hammond Glutathione dysregulation and the etiology and progression of human diseases Biol. Chem. 390 2009 191 214
115. R. Cheng, F. Feng, F. Meng, C. Deng, J. Feijen, and Z. Zhong Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery J. Control. Release 152 2011 2 12
116. W. Ong, Y. Yang, A.C. Cruciano, and R.L. McCarley Redox-triggered contents release from liposomes J. Am. Chem. Soc. 130 2008 14739 14744
117. P. Sun, D. Zhou, and Z. Gan Novel reduction-sensitive micelles for triggered intracellular drug release J. Control. Release 155 2011 96 103
118. B. Goldenbogen, N. Brodersen, A. Gramatica, M. Loew, J. Liebscher, A. Herrmann, H. Egger, B. Budde, and A. Arbuzova Reduction-sensitive liposomes from a multifunctional lipid conjugate and natural phospholipids: reduction and release kinetics and cellular uptake Langmuir 27 2011 10820 10829
119. S.S. Dunn, S. Tian, S. Blake, J. Wang, A.L. Galloway, A. Murphy, P.D. Pohlhaus, J.P. Rolland, M.E. Napier, and J.M. DeSimone Reductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing J. Am. Chem. Soc. 134 2012 7423 7430
120. F. Perche, S. Biswas, T. Wang, L. Zhu, and V.P. Torchilin Hypoxia-targeted siRNA delivery Angew. Chem. Int. Ed. Engl. 53 2014 3362 3366
121. G. Salzano, R. Riehle, G. Navarro, F. Perche, G. De Rosa, and V.P. Torchilin Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancer Cancer Lett. 343 2014 224 231
122. H. Xiao, W. Li, R. Qi, L. Yan, R. Wang, S. Liu, Y. Zheng, Z. Xie, Y. Huang, and X. Jing Co-delivery of daunomycin and oxaliplatin by biodegradable polymers for safer and more efficacious combination therapy J. Control. Release 163 2012 304 314
123. Q. Yin, J. Shen, L. Chen, Z. Zhang, W. Gu, and Y. Li Overcoming multidrug resistance by co-delivery of Mdr-1 and survivin-targeting RNA with reduction-responsible cationic poly(β-amino esters) Biomaterials 33 2012 6495 6506
124. K. Nam, H.Y. Nam, P.-H. Kim, and S.W. Kim Paclitaxel-conjugated PEG and arginine-grafted bioreducible poly (disulfide amine) micelles for co-delivery of drug and gene Biomaterials 33 2012 8122 8130
125. H. Kagaya, M. Oba, Y. Miura, H. Koyama, T. Ishii, T. Shimada, T. Takato, K. Kataoka, and T. Miyata Impact of polyplex micelles installed with cyclic RGD peptide as ligand on gene delivery to vascular lesions Gene Ther. 19 2012 61 69
126. F. Zhao, H. Yin, and J. Li Supramolecular self-assembly forming a multifunctional synergistic system for targeted co-delivery of gene and drug Biomaterials 35 2014 1050 1062
127. K. Kono Thermosensitive polymer-modified liposomes Adv. Drug Deliv. Rev. 53 2001 307 319 (Pubitemid 34024912)
128. A. Chilkoti, M.R. Dreher, D.E. Meyer, and D. Raucher Targeted drug delivery by thermally responsive polymers Adv. Drug Deliv. Rev. 54 2002 613 630 (Pubitemid 35247519)
129. A. Schwerdt, A. Zintchenko, M. Concia, N. Roesen, K. Fisher, L.H. Lindner, R. Issels, E. Wagner, and M. Ogris Hyperthermia-induced targeting of thermosensitive gene carriers to tumors Hum. Gene Ther. 19 2008 1283 1292
130. M. Yang, Y. Ding, L. Zhang, X. Qian, X. Jiang, and B. Liu Novel thermosensitive polymeric micelles for docetaxel delivery J. Biomed. Mater. Res. A 81A 2007 847 857
131. B. Sahoo, K.S. Devi, R. Banerjee, T.K. Maiti, P. Pramanik, and D. Dhara Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug ACS Appl. Mater. Interfaces 5 2013 3884 3893
132. W. Xiong, W. Wang, Y. Wang, Y. Zhao, H. Chen, H. Xu, and X. Yang Dual temperature/pH-sensitive drug delivery of poly(N-isopropylacrylamide-co-acrylic acid) nanogels conjugated with doxorubicin for potential application in tumor hyperthermia therapy Colloids Surf. B: Biointerfaces 84 2011 447 453
133. T. Ta, A.J. Convertine, C.R. Reyes, P.S. Stayton, and T.M. Porter Thermosensitive liposomes modified with poly(N-isopropylacrylamide-co- propylacrylic acid) copolymers for triggered release of doxorubicin Biomacromolecules 11 2010 1915 1920
134. C. de las Heras Alarcon, S. Pennadam, and C. Alexander Stimuli responsive polymers for biomedical applications Chem. Soc. Rev. 34 2005 276 285 (Pubitemid 40444408)
135. C. Cheng, H. Wei, X.-Z. Zhang, S.-X. Cheng, and R.-X. Zhuo Thermo-triggered and biotinylated biotin-P(NIPAAm-co-HMAAm)-b-PMMA micelles for controlled drug release J. Biomed. Mater. Res. A 88A 2009 814 822
136. J.E. Chung, M. Yokoyama, M. Yamato, T. Aoyagi, Y. Sakurai, and T. Okano Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate) J. Control. Release 62 1999 115 127 (Pubitemid 29486490)
137. F. Kohori, K. Sakai, T. Aoyagi, M. Yokoyama, Y. Sakurai, and T. Okano Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-dl-lactide) J. Control. Release 55 1998 87 98 (Pubitemid 28477567)
138. R. Salehi, H. Hamishehkar, M. Eskandani, M. Mahkam, and S. Davaran Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs J. Drug Target. 22 2014 327 342
139. Z. Peng, C. Wang, E. Fang, X. Lu, G. Wang, and Q. Tong Co-delivery of doxorubicin and SATB1 shRNA by thermosensitive magnetic cationic liposomes for gastric cancer therapy PLoS ONE 9 2014 e92924
140. D.-D. Guo, S.-H. Hong, H.-L. Jiang, J.-H. Kim, A. Minai-Tehrani, J.-E. Kim, J.-Y. Shin, T. Jiang, Y.-K. Kim, Y.-J. Choi, C.-S. Cho, and M.-H. Cho Synergistic effects of Akt1 shRNA and paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel on breast cancer Biomaterials 33 2012 2272 2281
141. N.S. Rejinold, T. Baby, K.P. Chennazhi, and R. Jayakumar Dual drug encapsulated thermo-sensitive fibrinogen-graft-poly (N-isopropyl acrylamide) nanogels for breast cancer therapy Colloids Surf. B: Biointerfaces 114 2014 209 217
142. B. Zhang, F. Jia, M.Q. Fleming, and S.K. Mallapragada Injectable self-assembled block copolymers for sustained gene and drug co-delivery: an in vitro study Int. J. Pharm. 427 2012 88 96
143. P. Tartaj, M.d.P. Morales, S. Veintemillas-Verdaguer, T. González-Carreño, and C.J. Serna The preparation of magnetic nanoparticles for applications in biomedicine J. Phys. D. Appl. Phys. 36 2003 R182 R197
144. I. Šafařík, and M. Šafaří ková Magnetic nanoparticles and biosciences H. Hofmann, Z. Rahman, U. Schubert, Nanostructured Materials 2002 Springer Vienna 1 23
145. P.B. Santhosh, and N.P. Ulrih Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics Cancer Lett. 336 2013 8 17
146. R.K. Singh, K.D. Patel, J.J. Kim, T.H. Kim, J.H. Kim, U.S. Shin, E.J. Lee, J.C. Knowles, and H.W. Kim Multifunctional hybrid nanocarrier: magnetic CNTs ensheathed with mesoporous silica for drug delivery and imaging system ACS Appl. Mater. Interfaces 6 2014 2201 2208
147. J. Shi, X. Yu, L. Wang, Y. Liu, J. Gao, J. Zhang, R. Ma, R. Liu, and Z. Zhang PEGylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and MR imaging Biomaterials 34 2013 9666 9677
148. A.J. Villaraza, A. Bumb, and M.W. Brechbiel Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics Chem. Rev. 110 2010 2921 2959
149. P. Mi, D. Kokuryo, H. Cabral, M. Kumagai, T. Nomoto, I. Aoki, Y. Terada, A. Kishimura, N. Nishiyama, and K. Kataoka Hydrothermally synthesized PEGylated calcium phosphate nanoparticles incorporating Gd-DTPA for contrast enhanced MRI diagnosis of solid tumors J. Control. Release 174 2014 63 71
150. S. Govindarajan, K. Kitaura, M. Takafuji, H. Ihara, K.S. Varadarajan, A.B. Patel, and V. Gopal Gene delivery into human cancer cells by cationic lipid-mediated magnetofection Int. J. Pharm. 446 2013 87 99
151. S. Laurent, S. Dutz, U.O. Hafeli, and M. Mahmoudi Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles Adv. Colloid Interf. Sci. 166 2011 8 23
152. G. Kong, and M.W. Dewhirst Hyperthermia and liposomes Int. J. Hyperthermia 15 1999 345 370 (Pubitemid 29425711)
153. Y. Cui, Q. Xu, P.K. Chow, D. Wang, and C.H. Wang Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment Biomaterials 34 2013 8511 8520
154. Q. Liu, J. Zhang, W. Sun, Q.R. Xie, W. Xia, and H. Gu Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells Int. J. Nanomedicine 7 2012 999 1013
155. A. Singh, F. Dilnawaz, S. Mewar, U. Sharma, N.R. Jagannathan, and S.K. Sahoo Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy ACS Appl. Mater. Interfaces 3 2011 842 856
156. S.H. Hu, B.J. Liao, C.S. Chiang, P.J. Chen, I.W. Chen, and S.Y. Chen Core-shell nanocapsules stabilized by single-component polymer and nanoparticles for magneto-chemotherapy/hyperthermia with multiple drugs Adv. Mater. 24 2012 3627 3632
157. F. Dilnawaz, A. Singh, C. Mohanty, and S.K. Sahoo Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy Biomaterials 31 2010 3694 3706
158. C. Oerlemans, W. Bult, M. Bos, G. Storm, J.F. Nijsen, and W.E. Hennink Polymeric micelles in anticancer therapy: targeting, imaging and triggered release Pharm. Res. 27 2010 2569 2589
159. Y. Zhao Rational design of light-controllable polymer micelles Chem. Rec. 7 2007 286 294
160. N. Fomina, J. Sankaranarayanan, and A. Almutairi Photochemical mechanisms of light-triggered release from nanocarriers Adv. Drug Deliv. Rev. 64 2012 1005 1020
161. Q. Yan, D. Han, and Y. Zhao Main-chain photoresponsive polymers with controlled location of light-cleavable units: from synthetic strategies to structural engineering Polym. Chem. 4 2013 5026 5037
162. C.J. Rijcken, O. Soga, W.E. Hennink, and C.F. van Nostrum Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery J. Control. Release 120 2007 131 148 (Pubitemid 47058635)
163. R. Tong, H.D. Hemmati, R. Langer, and D.S. Kohane Photoswitchable nanoparticles for triggered tissue penetration and drug delivery J. Am. Chem. Soc. 134 2012 8848 8855
164. G.-Y. Liu, C.-J. Chen, D.-D. Li, S.-S. Wang, and J. Ji Near-infrared light-sensitive micelles for enhanced intracellular drug delivery J. Mater. Chem. 22 2012 16865 16871
165. A. Yavlovich, A. Singh, R. Blumenthal, and A. Puri A novel class of photo-triggerable liposomes containing DPPC:DC(8,9)PC as vehicles for delivery of doxorubcin to cells Biochim. Biophys. Acta 1808 2011 117 126
166. D.E. Dolmans, D. Fukumura, and R.K. Jain Photodynamic therapy for cancer Nat. Rev. Cancer 3 2003 380 387 (Pubitemid 37328858)
167. Z. Huang A review of progress in clinical photodynamic therapy Technol. Cancer Res. Treat. 4 2005 283 293 (Pubitemid 40807688)
168. H.F. Ji, and L. Shen Triplet excited state characters and photosensitization mechanisms of alpha-terthienyl: a theoretical study J. Photochem. Photobiol. B 94 2009 51 53
169. Y.T. Chang, P.Y. Liao, H.S. Sheu, Y.J. Tseng, F.Y. Cheng, and C.S. Yeh Near-infrared light-responsive intracellular drug and siRNA release using au nanoensembles with oligonucleotide-capped silica shell Adv. Mater. 24 2012 3309 3314
170. N.Z. Knezevic, and V.S. Lin A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug Nanoscale 5 2013 1544 1551
171. C. Conte, F. Ungaro, G. Maglio, P. Tirino, G. Siracusano, M.T. Sciortino, N. Leone, G. Palma, A. Barbieri, C. Arra, A. Mazzaglia, and F. Quaglia Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer J. Control. Release 167 2013 40 52
172. T.H. Tran, B.C. Bae, Y.K. Lee, K. Na, and K.M. Huh Heparin-folate- retinoic acid bioconjugates for targeted delivery of hydrophobic photosensitizers Carbohydr. Polym. 92 2013 1615 1624
173. H.L. Lu, W.J. Syu, N. Nishiyama, K. Kataoka, and P.S. Lai Dendrimer phthalocyanine-encapsulated polymeric micelle-mediated photochemical internalization extends the efficacy of photodynamic therapy and overcomes drug-resistance in vivo J. Control. Release 155 2011 458 464
174. M. Gary-Bobo, O. Hocine, D. Brevet, M. Maynadier, L. Raehm, S. Richeter, V. Charasson, B. Loock, A. Morere, P. Maillard, M. Garcia, and J.O. Durand Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT Int. J. Pharm. 423 2012 509 515
175. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
176. C.-S. Chiang, S.-H. Hu, B.-J. Liao, Y.-C. Chang, and S.-Y. Chen Enhancement of cancer therapy efficacy by trastuzumab-conjugated and pH-sensitive nanocapsules with the simultaneous encapsulation of hydrophilic and hydrophobic compounds Nanomedicine 10 2014 99 107
177. J.-M. Shen, F.-Y. Gao, T. Yin, H.-X. Zhang, M. Ma, Y.-J. Yang, and F. Yue cRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapy Pharmacol. Res. 70 2013 102 115
178. E. Waltz It's official: biologics are pharma's darlings Nat. Biotechnol. 32 2014 117